Table of Contents

2019-2024 Global Zika Virus Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Zika Virus Consumption 2014-2024
  • 2.1.2 Zika Virus Consumption CAGR by Region
• 2.2 Zika Virus Segment by Type
  • 2.2.1 Sexual Transmission
  • 2.2.2 Blood Transfusion
• 2.3 Zika Virus Consumption by Type
  • 2.3.1 Global Zika Virus Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Zika Virus Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Zika Virus Sale Price by Type (2014-2019)
• 2.4 Zika Virus Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Ambulatory Surgery Centers
  • 2.4.4 Others
• 2.5 Zika Virus Consumption by Application
  • 2.5.1 Global Zika Virus Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Zika Virus Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Zika Virus Sale Price by Application (2014-2019)

3 Global Zika Virus by Players

• 3.1 Global Zika Virus Sales Market Share by Players
  • 3.1.1 Global Zika Virus Sales by Players (2017-2019)
  • 3.1.2 Global Zika Virus Sales Market Share by Players (2017-2019)
• 3.2 Global Zika Virus Revenue Market Share by Players
  • 3.2.1 Global Zika Virus Revenue by Players (2017-2019)
  • 3.2.2 Global Zika Virus Revenue Market Share by Players (2017-2019)
• 3.3 Global Zika Virus Sale Price by Players
• 3.4 Global Zika Virus Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Zika Virus Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Zika Virus Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Zika Virus by Regions

• 4.1 Zika Virus by Regions
  • 4.1.1 Global Zika Virus Consumption by Regions
  • 4.1.2 Global Zika Virus Value by Regions
• 4.2 Americas Zika Virus Consumption Growth
• 4.3 APAC Zika Virus Consumption Growth
• 4.4 Europe Zika Virus Consumption Growth
• 4.5 Middle East & Africa Zika Virus Consumption Growth

5 Americas

• 5.1 Americas Zika Virus Consumption by Countries
  • 5.1.1 Americas Zika Virus Consumption by Countries (2014-2019)
  • 5.1.2 Americas Zika Virus Value by Countries (2014-2019)
• 5.2 Americas Zika Virus Consumption by Type
• 5.3 Americas Zika Virus Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Zika Virus Consumption by Countries
  • 6.1.1 APAC Zika Virus Consumption by Countries (2014-2019)
  • 6.1.2 APAC Zika Virus Value by Countries (2014-2019)
• 6.2 APAC Zika Virus Consumption by Type
• 6.3 APAC Zika Virus Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Zika Virus by Countries
  • 7.1.1 Europe Zika Virus Consumption by Countries (2014-2019)
  • 7.1.2 Europe Zika Virus Value by Countries (2014-2019)
• 7.2 Europe Zika Virus Consumption by Type
• 7.3 Europe Zika Virus Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Zika Virus by Countries
  • 8.1.1 Middle East & Africa Zika Virus Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Zika Virus Value by Countries (2014-2019)
• 8.2 Middle East & Africa Zika Virus Consumption by Type
• 8.3 Middle East & Africa Zika Virus Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Zika Virus Distributors
• 10.3 Zika Virus Customer

11 Global Zika Virus Market Forecast

• 11.1 Global Zika Virus Consumption Forecast (2019-2024)
• 11.2 Global Zika Virus Forecast by Regions
  • 11.2.1 Global Zika Virus Forecast by Regions (2019-2024)
  • 11.2.2 Global Zika Virus Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Zika Virus Forecast by Type
• 11.8 Global Zika Virus Forecast by Application

12 Key Players Analysis

• 12.1 Bharat Biotech
  • 12.1.1 Company Details
  • 12.1.2 Zika Virus Product Offered
  • 12.1.3 Bharat Biotech Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bharat Biotech News
• 12.2 Inovio Pharmaceuticals and GeneOne Life Sciences
  • 12.2.1 Company Details
  • 12.2.2 Zika Virus Product Offered
  • 12.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences News
• 12.3 Intrexon
  • 12.3.1 Company Details
  • 12.3.2 Zika Virus Product Offered
  • 12.3.3 Intrexon Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Intrexon News
• 12.4 Cerus
  • 12.4.1 Company Details
  • 12.4.2 Zika Virus Product Offered
  • 12.4.3 Cerus Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Cerus News
• 12.5 Sanofi
  • 12.5.1 Company Details
  • 12.5.2 Zika Virus Product Offered
  • 12.5.3 Sanofi Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Sanofi News
• 12.6 NewLink Genetics
  • 12.6.1 Company Details
  • 12.6.2 Zika Virus Product Offered
  • 12.6.3 NewLink Genetics Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 NewLink Genetics News
• 12.7 Immunovaccine
  • 12.7.1 Company Details
  • 12.7.2 Zika Virus Product Offered
  • 12.7.3 Immunovaccine Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Immunovaccine News
• 12.8 GlaxoSmithKline
  • 12.8.1 Company Details
  • 12.8.2 Zika Virus Product Offered
  • 12.8.3 GlaxoSmithKline Zika Virus Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 GlaxoSmithKline News

13 Research Findings and Conclusion

Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections.
Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. Based on research to date, there is scientific consensus that Zika virus is a cause of microcephaly and GBS.
Zika virus is primarily transmitted to people through the bite of an infected mosquito from the Aedes genus, mainly Aedes aegypti in tropical regions. Sexual transmission of Zika virus is also possible. Other modes of transmission such as blood transfusion are being investigated.
Zika virus is a mosquito-borne flavivirus that was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Outbreaks of Zika virus disease have been recorded in Africa, the Americas, Asia and the Pacific. From the 1960s to 1980s, human infections were found across Africa and Asia, typically accompanied by mild illness. The first large outbreak of disease caused by Zika infection was reported from the Island of Yap (Federated States of Micronesia) in 2007. In July 2015 Brazil reported an association between Zika virus infection and Guillain-Barré syndrome. In October 2015 Brazil reported an association between Zika virus infection and microcephaly.

According to this study, over the next five years the Zika Virus market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Zika Virus business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Zika Virus market by product type, application, key manufacturers and key regions and countries.

This study considers the Zika Virus value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Sexual Transmission
Blood Transfusion
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Ambulatory Surgery Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Zika Virus consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Zika Virus market by identifying its various subsegments.
Focuses on the key global Zika Virus manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Zika Virus with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Zika Virus submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.